![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM130 |
Gene summary for TMEM130 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM130 | Gene ID | 222865 |
Gene name | transmembrane protein 130 | |
Gene Alias | TMEM130 | |
Cytomap | 7q22.1 | |
Gene Type | protein-coding | GO ID | GO:0000139 | UniProtAcc | Q8N3G9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
222865 | TMEM130 | HCC1 | Human | Liver | HCC | 3.04e-11 | 1.22e+00 | 0.5336 |
222865 | TMEM130 | HCC2 | Human | Liver | HCC | 3.31e-22 | 1.49e+00 | 0.5341 |
222865 | TMEM130 | HCC5 | Human | Liver | HCC | 1.75e-23 | 1.42e+00 | 0.4932 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM130 | SNV | Missense_Mutation | rs756989914 | c.466N>A | p.Val156Ile | p.V156I | Q8N3G9 | protein_coding | tolerated(0.28) | benign(0.001) | TCGA-B6-A0IB-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
TMEM130 | insertion | Frame_Shift_Ins | novel | c.1222_1223insA | p.Thr408AsnfsTer4 | p.T408Nfs*4 | Q8N3G9 | protein_coding | TCGA-A7-A4SA-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR | ||
TMEM130 | SNV | Missense_Mutation | c.748N>A | p.Pro250Thr | p.P250T | Q8N3G9 | protein_coding | deleterious(0.04) | possibly_damaging(0.719) | TCGA-DS-A1OA-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | carboplatin | PD | |
TMEM130 | deletion | Frame_Shift_Del | novel | c.951_966delCGAGAATATCATCAGC | p.Glu318ArgfsTer30 | p.E318Rfs*30 | Q8N3G9 | protein_coding | TCGA-VS-A9V2-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | ||
TMEM130 | SNV | Missense_Mutation | rs142570247 | c.1087N>T | p.Arg363Trp | p.R363W | Q8N3G9 | protein_coding | deleterious(0.03) | probably_damaging(0.958) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
TMEM130 | SNV | Missense_Mutation | rs539482079 | c.517N>A | p.Ala173Thr | p.A173T | Q8N3G9 | protein_coding | deleterious(0) | possibly_damaging(0.879) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
TMEM130 | SNV | Missense_Mutation | rs539482079 | c.517G>A | p.Ala173Thr | p.A173T | Q8N3G9 | protein_coding | deleterious(0) | possibly_damaging(0.879) | TCGA-AA-A01R-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5-fluorouracil | PD |
TMEM130 | SNV | Missense_Mutation | c.1084N>A | p.Leu362Met | p.L362M | Q8N3G9 | protein_coding | tolerated(0.1) | possibly_damaging(0.735) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM130 | SNV | Missense_Mutation | rs782057076 | c.848N>T | p.Pro283Leu | p.P283L | Q8N3G9 | protein_coding | deleterious(0.01) | possibly_damaging(0.579) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM130 | SNV | Missense_Mutation | rs376067598 | c.295G>A | p.Val99Met | p.V99M | Q8N3G9 | protein_coding | tolerated(0.12) | benign(0.01) | TCGA-NH-A5IV-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |